# Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children

> **NCT01407887** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 180 (actual)

## Conditions studied

- Uncomplicated Falciparum Malaria

## Interventions

- **DRUG:** artesunate (AS) - amodiaquine (AQ) - methylene blue (MB)

## Key facts

- **NCT ID:** NCT01407887
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2012-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407887, "Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01407887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*